Based on the Theriva Biologics Inc. stock forecast from 0 analysts, the average analyst target price for Theriva Biologics Inc. is not available over the next 12 months. Theriva Biologics Inc.’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Theriva Biologics Inc. is Very Bullish, which is based on 1 positive signals and 0 negative signals. At the last closing, Theriva Biologics Inc.’s stock price was USD 1.65. Theriva Biologics Inc.’s stock price has changed by +33.06% over the past week, -60.34% over the past month and +250.32% over the last year.
Analyst Ratings
Target Price Action
Rating Action
Analyst
Rating
Price
Date
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
There is nothing we particularly dislike
Add to Watchlists
loading..
Download Confirmation
Premium customers can only download records visible on the current page view, while Platinum customers can download the first 1000 records.
Paid-only feature
CSV downloads are only available for paying customers.
Thank you for Sharing your Stock Targets for TOVX !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
